Tongue Cancer Worse in Older People
Posted on: Monday, 18 September 2006, 15:00 CDT
A Swedish study finds that the prognosis for patients age 60 and older with tongue cancer was worse than the outcomes for younger patients.
From 1988-2004, 105 patients with small tongue cancers less than 4 cm in size received treatment at the Orebro University Hospital. Forty-eight, or 46 percent, of the subjects were male, 57, or 54 percent, were female. The median age of the subjects was 61.
Fifty of the patients were treated primarily with surgery, 51 with external beam radiotherapy. Thirty-six patients had one treatment; the rest received additional treatment.
Sixty-five percent of the subjects survived two years without the disease, while 29 percent died within five years from disease; however, 37 percent of patients 60 and older died of the disease compared to 20 percent of the younger patients, according to study leader Dr. Anders Westerborn of Orebro University Hospital.
The findings are being presented at the 110th annual meeting of the American Academy of Otolaryngology -- Head and Neck Surgery Foundation in Toronto.
Source: United Press International
Related Articles
- 8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds
- New Findings Could Improve Care Of Patients Suffering From Rheumatic Diseases
- Surveyed Neurologists in Both the United States and Europe Indicate That a Once-Daily Transdermal Formulation of Levodopa Would Earn a 30 Percent Patient Share in Parkinson's Disease
- Nursing Research Grants Available to Improve Treatment of Patients With Auto-Immune Diseases and Cancer
- Only 44.4 Percent of Parkinson's Disease Patients Receive Drug Treatment Within One Year of Being Diagnosed
- High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients With Chronic Kidney Disease
- Positive Findings From Clinical Studies of QUADRAMET(R) in Prostate Cancer Patients With Metastatic Bone Disease Presented at ASCO Prostate Cancer Symposium
- Benephit Infusion System To Be Studied in Patients With Chronic Kidney Disease Undergoing Cardiovascular Procedures
- Pfizer's Norvasc Demonstrates Significant Reductions in Major Cardiovascular Events in Patients With Coronary Artery Disease
- Actelion Ltd.: New Scientific Studies Show Higher Than Expected Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases (CTD)
 |
 |
User Comments (0)
RSS Feeds